Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
The Core Decision First Before the hour-by-hour plan, one thing must be settled in your own mind, because everything else flows from it: you disclose, and you disclose fast. Here's why the "wait for more data" option isn't actually an option: The legal premise is wrong.Read the full answer
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer